Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

SiriusPoint (SPNT) Financials

SiriusPoint logo
$18.40 -0.21 (-1.12%)
Closing price 08/28/2025 03:59 PM Eastern
Extended Trading
$18.41 +0.01 (+0.05%)
As of 08/28/2025 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for SiriusPoint

Annual Income Statements for SiriusPoint

This table shows SiriusPoint's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -87 28 278 -318 201 144 58 -387 355 200
Consolidated Net Income / (Loss)		 -87 29 282 -317 201 144 56 -386 364 202
Net Income / (Loss) Continuing Operations		 -87 29 282 -317 201 144 56 -386 364 202
Total Pre-Tax Income 		-90 34 294 -321 201 152 45 -423 319 233
Total Revenue		 578 700 906 360 971 876 2,191 2,133 2,638 2,544
Net Interest Income / (Expense)		 0.00 0.00 -8.23 -8.23 -8.20 -8.20 -34 -39 -64 -70
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 8.23 8.23 8.20 8.20 34 39 64 70
Long-Term Debt Interest Expense		 - - 8.23 8.23 8.20 8.20 34 39 64 70
Total Non-Interest Income		 578 700 914 368 979 885 2,225 2,172 2,702 2,614
Other Service Charges		 - -8.39 -13 -9.61 18 0.00 151 83 98 184
Net Realized & Unrealized Capital Gains on Investments		 -25 118 380 -244 261 274 357 -229 178 86
Premiums Earned		 603 590 547 621 700 611 1,717 2,318 2,426 2,344
Total Non-Interest Expense		 668 666 612 681 770 724 2,146 2,556 2,320 2,311
Property & Liability Insurance Claims		 415 396 370 438 404 465 1,327 1,588 1,381 1,369
Insurance Policy Acquisition Costs		 191 222 - - 34 30 159 185 196 182
Other Operating Expenses		 62 48 53 36 36 42 267 313 258 232
Amortization Expense		 - - 189 206 0.00 0.00 5.90 8.10 11 12
Restructuring Charge		 - - - - 296 187 388 462 473 517
Income Tax Expense		 -2.91 5.59 12 -4.01 0.70 8.10 -11 -37 -45 31
Preferred Stock Dividends Declared		 - - - - 0.00 0.00 14 16 16 16
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.05 1.24 3.97 0.22 0.00 0.30 -2.30 0.80 8.90 2.50
Basic Earnings per Share		 ($0.84) $0.26 $2.71 ($3.27) $2.18 $1.54 $0.28 ($2.51) $1.93 $1.06
Weighted Average Basic Shares Outstanding		 104.00M 104.06M 102.26M 97.05M 91.84M 92.51M 148.67M 160.23M 163.34M 166.54M
Diluted Earnings per Share		 ($0.84) $0.26 $2.64 ($3.27) $2.16 $1.53 $0.27 ($2.51) $1.85 $1.04
Weighted Average Diluted Shares Outstanding		 104.00M 105.56M 105.23M 97.05M 92.65M 92.96M 150.16M 160.23M 169.61M 169.47M
Weighted Average Basic & Diluted Shares Outstanding		 106.13M 106.30M 102.50M 97.20M 94.21M 191.17M 162.36M 162.38M 169.80M 162.23M

Quarterly Income Statements for SiriusPoint

This table shows SiriusPoint's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -94 -23 136 60 62 98 95 114 8.50 -17 62
Consolidated Net Income / (Loss)		 -94 -23 138 62 64 100 96 115 8.70 -17 62
Net Income / (Loss) Continuing Operations		 -94 -19 138 62 64 100 96 115 8.70 -17 62
Total Pre-Tax Income 		-93 -43 164 78 79 -1.90 106 129 11 -13 75
Total Revenue		 640 602 665 682 685 607 669 724 545 606 711
Net Interest Income / (Expense)		 -9.40 -11 -13 -12 -20 -20 -21 -16 -14 -20 -18
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 9.40 11 13 12 20 20 21 16 14 20 18
Long-Term Debt Interest Expense		 9.40 11 13 12 20 20 21 16 14 20 18
Total Non-Interest Income		 649 612 678 693 704 627 689 740 559 626 730
Other Service Charges		 13 -13 8.80 5.30 22 62 12 130 18 25 30
Net Realized & Unrealized Capital Gains on Investments		 23 18 74 48 70 -13 84 20 -28 11 73
Premiums Earned		 613 607 596 640 613 578 594 591 569 590 627
Total Non-Interest Expense		 732 640 501 604 606 609 563 595 534 619 636
Property & Liability Insurance Claims		 498 390 267 376 373 365 318 364 318 369 402
Insurance Policy Acquisition Costs		 45 46 52 43 37 64 42 41 45 54 41
Other Operating Expenses		 71 -20 60 70 63 65 56 67 51 58 61
Amortization Expense		 2.10 2.10 2.40 2.90 2.90 2.90 2.90 3.00 3.00 3.00 2.90
Restructuring Charge		 117 - 120 112 130 112 145 120 118 135 130
Income Tax Expense		 0.90 -20 26 16 15 -102 9.70 14 2.40 4.40 13
Preferred Stock Dividends Declared		 4.00 - 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.80 -0.40 2.40 2.00 2.30 2.20 1.10 0.90 0.20 0.30 0.40
Basic Earnings per Share		 ($0.61) ($0.16) $0.76 $0.32 $0.33 $0.52 $0.50 $0.60 $0.03 ($0.07) $0.50
Weighted Average Basic Shares Outstanding		 160.32M 160.23M 160.91M 162.03M 163.74M 163.34M 168.93M 170.17M 165.66M 166.54M 115.98M
Diluted Earnings per Share		 ($0.61) ($0.16) $0.74 $0.31 $0.32 $0.48 $0.49 $0.57 $0.03 ($0.05) $0.49
Weighted Average Diluted Shares Outstanding		 160.32M 160.23M 164.13M 166.71M 168.52M 169.61M 174.38M 178.71M 172.80M 169.47M 118.56M
Weighted Average Basic & Diluted Shares Outstanding		 162.17M 162.38M 162.95M 164.50M 167.58M 169.80M 170.48M 170.90M 161.87M 162.23M 116.59M

Annual Cash Flow Statements for SiriusPoint

This table details how cash moves in and out of SiriusPoint's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -8.33 -42 240 164 941 60 235 -1,035 188 -207
Net Cash From Operating Activities		 188 4.77 -79 13 141 73 1.60 293 581 75
Net Cash From Continuing Operating Activities		 188 4.77 -79 13 141 73 1.60 293 581 75
Net Income / (Loss) Continuing Operations		 -87 29 282 -317 201 144 56 -386 364 202
Consolidated Net Income / (Loss)		 -87 29 282 -317 201 144 56 -386 364 202
Amortization Expense		 0.32 5.12 0.47 4.13 -1.40 -3.80 15 -9.10 -56 -49
Non-Cash Adjustments to Reconcile Net Income		 23 -116 -464 244 -217 -221 -412 393 97 89
Changes in Operating Assets and Liabilities, net		 252 87 103 83 159 155 342 295 176 -168
Net Cash From Investing Activities		 -164 -85 265 378 787 6.00 209 -1,304 -332 344
Net Cash From Continuing Investing Activities		 -164 -85 265 378 787 6.00 209 -1,304 -332 344
Purchase of Investment Securities		 -3,905 -5,003 -3,891 -4,474 -418 -431 -3,410 -6,537 -4,962 -2,732
Sale and/or Maturity of Investments		 3,661 4,551 4,306 4,419 1,206 532 2,888 5,228 4,624 3,070
Other Investing Activities, net		 80 367 -150 432 -0.90 -95 78 4.50 5.50 6.20
Net Cash From Financing Activities		 -32 38 54 -227 13 -19 24 -24 -62 -625
Net Cash From Continuing Financing Activities		 -32 38 54 -227 13 -19 24 -24 -62 -625
Net Change in Deposits		 -66 22 19 9.79 11 -20 -14 -14 -6.10 -94
Issuance of Debt		 113 - - - - - - 0.00 0.00 394
Repayment of Debt		 - - - - - - - 0.00 0.00 -518
Repurchase of Common Equity		 0.00 -7.39 -41 -139 - 0.00 0.00 -5.00 0.00 -300
Payment of Dividends		 - - - -98 0.00 0.00 -12 -16 -16 -16
Other Financing Activities, Net		 -84 18 74 -0.07 -0.10 0.80 -0.30 11 -39 -91
Cash Interest Paid		 9.31 23 21 26 8.10 8.30 39 39 46 66
Cash Income Taxes Paid		 4.43 5.95 7.81 7.27 0.00 0.10 15 -2.20 50 51

Quarterly Cash Flow Statements for SiriusPoint

This table details how cash moves in and out of SiriusPoint's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -566 102 61 -203 40 290 -15 -362 91 79 31
Net Cash From Operating Activities		 200 48 94 112 162 213 56 -147 58 108 -89
Net Cash From Continuing Operating Activities		 200 48 94 112 162 213 56 -147 58 108 -89
Net Income / (Loss) Continuing Operations		 -94 -23 138 62 64 100 96 115 8.70 -17 62
Consolidated Net Income / (Loss)		 -94 -23 138 62 64 100 96 115 8.70 -17 62
Amortization Expense		 -8.20 -13 -18 -13 -18 -6.70 -15 -14 -12 -8.40 -6.40
Non-Cash Adjustments to Reconcile Net Income		 -15 114 14 -22 60 45 7.30 27 26 29 25
Changes in Operating Assets and Liabilities, net		 317 -30 -41 85 56 75 -32 -276 36 105 -169
Net Cash From Investing Activities		 -759 60 6.10 -304 -98 63 -78 16 202 203 611
Net Cash From Continuing Investing Activities		 -759 60 6.10 -304 -98 63 -78 16 202 203 611
Purchase of Investment Securities		 -1,733 -1,884 -1,259 -1,833 -859 -1,010 -977 -837 -480 -438 -523
Sale and/or Maturity of Investments		 923 1,945 1,207 1,573 754 1,090 856 886 685 643 1,153
Other Investing Activities, net		 51 -1.30 59 -44 7.70 -17 44 -33 -2.40 -2.40 -19
Net Cash From Financing Activities		 -7.30 -5.40 -39 -12 -24 14 7.10 -232 -169 -232 -491
Net Cash From Continuing Financing Activities		 -7.30 -5.40 -39 -12 -24 14 7.10 -232 -169 -232 -491
Net Change in Deposits		 -2.90 -1.30 3.80 -11 -0.30 1.50 -3.00 -99 3.90 3.80 3.90
Repurchase of Common Equity		 - - - - - - - - - -170 -491
Payment of Dividends		 -4.00 -4.00 -4.00 -4.00 -4.00 -4.00 -4.00 -4.00 -4.00 -4.00 -4.00
Other Financing Activities, Net		 -0.40 -0.10 -39 3.40 -20 16 14 -4.50 -39 -61 -0.50

Annual Balance Sheets for SiriusPoint

This table presents SiriusPoint's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 3,545 3,896 4,672 3,086 3,440 3,535 10,618 11,036 12,872 12,525
Cash and Due from Banks		 20 9.95 8.20 104 639 526 1,000 705 969 682
Restricted Cash		 331 299 541 609 1,015 1,188 949 208 132 213
Trading Account Securities		 2,265 2,565 2,958 1,524 986 105 4,530 5,654 6,078 5,706
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 11 6.51 3.77 1.32 2.18 0.90 8.30 27 42 44
Customer and Other Receivables		 - - - - - - 250 19 3.00 0.00
Unearned Premiums Asset		 294 382 477 620 619 477 3,166 3,602 4,711 4,834
Deferred Acquisition Cost		 197 222 259 204 155 69 219 295 309 328
Intangible Assets		 - - - - - 0.00 172 164 153 141
Other Assets		 426 412 425 24 25 1,170 325 363 475 579
Total Liabilities & Shareholders' Equity		 3,545 3,896 4,672 3,086 3,440 3,535 10,618 11,036 12,872 12,525
Total Liabilities		 2,149 2,446 2,902 1,882 2,026 1,970 8,115 8,954 10,341 10,586
Non-Interest Bearing Deposits		 84 105 129 145 172 153 151 141 134 17
Short-Term Debt		 697 1,013 914 114 114 0.00 6.50 18 6.20 18
Long-Term Debt		 - - 0.00 2.30 - 114 817 778 786 639
Claims and Claim Expense		 466 605 721 937 1,112 1,310 4,841 5,269 5,608 5,654
Unearned Premiums Liability		 532 557 650 603 525 285 1,198 1,521 1,627 1,639
Other Long-Term Liabilities		 358 155 455 73 85 90 1,101 1,227 2,179 2,619
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,396 1,450 1,661 1,205 1,414 1,565 2,503 2,083 2,531 1,939
Total Preferred & Common Equity		 1,380 1,414 1,656 1,205 1,414 1,564 2,504 2,075 2,514 1,937
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 200 200 200 200
Total Common Equity		 1,380 1,414 1,656 1,205 1,414 1,564 2,304 1,875 2,314 1,737
Common Stock		 1,091 1,105 1,110 928 937 944 1,639 1,658 1,710 957
Retained Earnings		 289 316 594 276 477 620 665 262 601 785
Accumulated Other Comprehensive Income / (Loss)		 - - - - - 0.00 -0.20 -45 3.10 -4.10
Noncontrolling Interest		 16 36 5.41 - 0.00 1.40 -0.40 7.90 17 1.40

Quarterly Balance Sheets for SiriusPoint

This table presents SiriusPoint's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 10,998 11,807 12,623 12,591 13,136 12,764 12,683 12,281
Cash and Due from Banks		 647 764 676 704 868 598 641 740
Restricted Cash		 144 211 95 108 219 126 175 185
Trading Account Securities		 5,738 5,762 5,953 6,026 6,197 6,099 6,048 5,119
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 17 34 37 41 45 51 49 42
Unearned Premiums Asset		 3,641 4,115 5,010 4,837 4,856 4,808 4,735 5,091
Deferred Acquisition Cost		 279 357 340 333 321 342 330 369
Intangible Assets		 166 162 159 156 150 147 144 138
Other Assets		 366 392 348 385 481 594 561 597
Total Liabilities & Shareholders' Equity		 10,998 11,807 12,623 12,591 13,136 12,764 12,683 12,281
Total Liabilities		 8,905 9,559 10,355 10,326 10,515 10,059 9,986 10,254
Non-Interest Bearing Deposits		 139 141 138 136 129 22 20 16
Short-Term Debt		 34 80 39 39 61 40 23 6.60
Long-Term Debt		 762 779 766 764 771 649 661 664
Claims and Claim Expense		 5,201 5,319 5,339 5,449 5,565 5,606 5,702 5,763
Unearned Premiums Liability		 1,573 1,833 1,819 1,763 1,716 1,770 1,684 1,817
Other Long-Term Liabilities		 1,197 1,406 2,254 2,176 2,274 1,972 1,896 1,989
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,093 2,248 2,268 2,265 2,620 2,706 2,697 2,027
Total Preferred & Common Equity		 2,085 2,237 2,255 2,250 2,603 2,704 2,695 2,025
Preferred Stock		 200 200 200 200 200 200 200 200
Total Common Equity		 1,885 2,037 2,055 2,050 2,403 2,504 2,495 1,825
Common Stock		 1,649 1,659 1,662 1,678 1,728 1,730 1,607 956
Retained Earnings		 289 401 467 508 692 802 806 843
Accumulated Other Comprehensive Income / (Loss)		 -54 -23 -74 -135 -17 -28 82 26
Noncontrolling Interest		 8.30 11 13 15 18 1.40 1.60 1.50

Annual Metrics And Ratios for SiriusPoint

This table displays calculated financial ratios and metrics derived from SiriusPoint's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 9.02% 21.14% 29.37% -60.29% 169.91% -9.73% 149.99% -2.63% 23.69% -3.57%
EBITDA Growth		 -246.82% 143.98% 643.22% -207.86% 162.99% -25.91% -59.15% -813.72% 160.84% -30.03%
EBIT Growth		 -244.88% 138.15% 752.21% -209.44% 162.62% -24.54% -70.31% -1,037.25% 175.40% -26.86%
NOPAT Growth		 -211.52% 145.66% 875.80% -179.86% 189.14% -28.32% -61.20% -630.27% 222.92% -44.35%
Net Income Growth		 -254.19% 133.02% 875.80% -212.67% 163.19% -28.32% -61.20% -791.76% 194.22% -44.35%
EPS Growth		 -278.72% 130.95% 915.38% -223.86% 166.06% -29.17% -82.35% -1,029.63% 173.71% -43.78%
Operating Cash Flow Growth		 53.37% -97.46% -1,746.11% 117.05% 954.01% -48.05% -97.82% 18,231.25% 98.19% -87.15%
Free Cash Flow Firm Growth		 -15.46% -16.83% 118.01% 1,753.10% -100.60% -12.62% -20,734.10% 109.55% -153.09% 1,251.80%
Invested Capital Growth		 12.25% 17.66% 8.95% -50.78% 15.70% 9.91% 98.05% -13.46% 15.44% -21.88%
Revenue Q/Q Growth		 4.79% -5.94% 2.77% -41.28% 51.43% 15.21% 1.84% 9.54% 0.20% -0.03%
EBITDA Q/Q Growth		 39.86% -70.04% 44.79% -1,104.03% 250.43% 177.42% -82.28% 18.80% 19.79% -6.32%
EBIT Q/Q Growth		 38.99% -72.93% 44.35% -1,247.81% 250.09% 257.51% -86.63% 21.43% 13.01% -4.39%
NOPAT Q/Q Growth		 38.99% -75.65% 48.55% -975.45% 313.67% 270.44% -82.95% 20.84% 50.91% -36.57%
Net Income Q/Q Growth		 39.30% -75.65% 48.55% -1,335.05% 257.79% 270.44% -82.95% 22.77% 50.91% -36.57%
EPS Q/Q Growth		 39.57% -76.79% 49.15% -1,586.36% 277.05% 292.31% -90.49% 27.46% 52.89% -33.76%
Operating Cash Flow Q/Q Growth		 -27.30% 154.59% -353.57% 115.20% 60.71% -18.29% -97.07% 33.14% 39.77% -58.59%
Free Cash Flow Firm Q/Q Growth		 29.30% -30.16% -83.83% 55.63% -112.69% -20.29% 0.84% -28.33% -230.79% 13,178.57%
Invested Capital Q/Q Growth		 -3.07% -3.04% 14.18% -19.71% 2.04% 8.87% -4.26% -0.35% 8.31% -23.20%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 -15.58% 5.65% 32.48% -88.23% 20.59% 16.90% 2.76% -20.24% 9.96% 7.22%
EBIT Margin		 -15.63% 4.92% 32.43% -89.38% 20.74% 17.33% 2.06% -19.82% 12.08% 9.16%
Profit (Net Income) Margin		 -15.13% 4.12% 31.11% -88.27% 20.66% 16.41% 2.55% -18.10% 13.79% 7.96%
Tax Burden Percent		 96.78% 83.77% 95.92% 98.75% 99.65% 94.67% 123.73% 91.32% 114.12% 86.83%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 16.23% 4.08% 0.00% 0.35% 5.33% -23.73% 0.00% -14.12% 13.17%
Return on Invested Capital (ROIC)		 -3.20% 1.27% 10.95% -11.24% 14.08% 8.97% 2.23% -9.54% 11.73% 6.84%
ROIC Less NNEP Spread (ROIC-NNEP)		 -7.99% 1.27% 10.95% -29.19% 14.08% 8.97% 2.23% -20.67% 11.73% 6.84%
Return on Net Nonoperating Assets (RNNOA)		 -2.74% 0.76% 6.55% -10.11% 1.24% 0.69% 0.51% -7.30% 4.04% 2.22%
Return on Equity (ROE)		 -5.93% 2.03% 17.50% -21.35% 15.32% 9.65% 2.74% -16.83% 15.77% 9.06%
Cash Return on Invested Capital (CROIC)		 -14.74% -14.96% 2.39% 56.82% -0.48% -0.48% -63.57% 4.90% -2.60% 31.41%
Operating Return on Assets (OROA)		 -2.82% 0.93% 6.86% -8.29% 6.17% 4.36% 0.64% -3.90% 2.67% 1.84%
Return on Assets (ROA)		 -2.73% 0.78% 6.58% -8.18% 6.15% 4.12% 0.79% -3.57% 3.04% 1.59%
Return on Common Equity (ROCE)		 -5.70% 1.99% 16.69% -20.53% 15.32% 9.65% 2.61% -15.34% 14.32% 8.21%
Return on Equity Simple (ROE_SIMPLE)		 -6.34% 2.04% 17.01% -26.36% 14.19% 9.20% 2.23% -18.61% 14.47% 10.45%
Net Operating Profit after Tax (NOPAT)		 -63 29 282 -225 201 144 56 -296 364 202
NOPAT Margin		 -10.94% 4.12% 31.11% -62.57% 20.66% 16.41% 2.55% -13.87% 13.79% 7.96%
Net Nonoperating Expense Percent (NNEP)		 4.79% 0.00% 0.00% 17.95% 0.00% 0.00% 0.00% 11.13% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 115.63% 95.08% 67.57% 189.38% 79.26% 82.67% 97.94% 119.82% 87.92% 90.84%
Earnings before Interest and Taxes (EBIT)		 -90 34 294 -321 201 152 45 -423 319 233
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -90 40 294 -317 200 148 61 -432 263 184
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 1.03 0.87 0.95 0.75 0.70 0.58 0.57 0.51 0.84 1.53
Price to Tangible Book Value (P/TBV)		 1.03 0.87 0.95 0.75 0.70 0.58 0.62 0.56 0.90 1.66
Price to Revenue (P/Rev)		 2.45 1.76 1.74 2.52 1.02 1.04 0.60 0.45 0.74 1.04
Price to Earnings (P/E)		 0.00 44.46 5.66 0.00 4.94 6.34 22.66 0.00 5.48 13.27
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 2.25% 17.66% 0.00% 20.24% 15.78% 4.41% 0.00% 18.25% 7.53%
Enterprise Value to Invested Capital (EV/IC)		 0.85 0.80 0.76 0.24 0.00 0.00 0.12 0.36 0.56 1.01
Enterprise Value to Revenue (EV/Rev)		 3.07 2.81 2.26 0.86 0.00 0.00 0.18 0.49 0.70 1.03
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 49.73 6.97 0.00 0.00 0.00 6.46 0.00 7.05 14.24
Enterprise Value to EBIT (EV/EBIT)		 0.00 57.11 6.98 0.00 0.00 0.00 8.67 0.00 5.81 11.23
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 68.18 7.28 0.00 0.00 0.00 7.01 0.00 5.09 12.93
Enterprise Value to Operating Cash Flow (EV/OCF)		 9.46 412.63 0.00 23.21 0.00 0.00 244.34 3.57 3.19 35.03
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 33.41 0.27 0.00 0.00 0.00 6.89 0.00 2.82
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.50 0.70 0.52 0.10 0.08 0.07 0.33 0.38 0.31 0.34
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.07 0.33 0.37 0.31 0.33
Financial Leverage		 0.34 0.60 0.60 0.35 0.09 0.08 0.23 0.35 0.34 0.32
Leverage Ratio		 2.17 2.61 2.66 2.61 2.49 2.34 3.48 4.72 5.18 5.68
Compound Leverage Factor		 2.17 2.61 2.66 2.61 2.49 2.34 3.48 4.72 5.18 5.68
Debt to Total Capital		 33.31% 41.14% 34.05% 8.80% 7.47% 6.81% 24.75% 27.65% 23.85% 25.31%
Short-Term Debt to Total Capital		 33.31% 41.14% 34.05% 8.62% 7.47% 0.00% 0.20% 0.63% 0.19% 0.69%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.17% 0.00% 6.81% 24.55% 27.03% 23.66% 24.62%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.01% 6.95% 6.02% 7.70%
Noncontrolling Interests to Total Capital		 0.77% 1.45% 4.23% 0.00% 0.00% 0.08% -0.01% 0.27% 0.50% 0.05%
Common Equity to Total Capital		 65.92% 57.41% 61.72% 91.20% 92.53% 93.11% 69.25% 65.13% 69.63% 66.93%
Debt to EBITDA		 -7.75 25.59 3.11 -0.37 0.57 0.77 13.61 -1.84 3.02 3.58
Net Debt to EBITDA		 -3.84 17.79 1.24 1.88 -7.70 -10.80 -18.60 0.27 -1.18 -1.29
Long-Term Debt to EBITDA		 0.00 0.00 0.00 -0.01 0.00 0.77 13.50 -1.80 2.99 3.48
Debt to NOPAT		 -11.03 35.09 3.24 -0.52 0.57 0.79 14.75 -2.69 2.18 3.25
Net Debt to NOPAT		 -5.47 24.39 1.29 2.65 -7.68 -11.12 -20.16 0.40 -0.85 -1.17
Long-Term Debt to NOPAT		 0.00 0.00 0.00 -0.01 0.00 0.79 14.64 -2.63 2.16 3.16
Noncontrolling Interest Sharing Ratio		 3.94% 1.82% 4.64% 3.82% 0.00% 0.05% 4.94% 8.89% 9.20% 9.35%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -292 -341 61 1,137 -6.78 -7.64 -1,591 152 -81 930
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 7.46 138.24 -0.83 -0.93 -46.80 3.94 -1.26 13.35
Operating Cash Flow to Interest Expense		 0.00 0.00 -9.55 1.63 17.21 8.94 0.05 7.60 9.07 1.07
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 -9.55 1.63 17.21 8.94 0.05 7.60 9.07 1.07
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.18 0.19 0.21 0.09 0.30 0.25 0.31 0.20 0.22 0.20
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 2,093 2,463 2,683 1,321 1,528 1,680 3,327 2,879 3,323 2,596
Invested Capital Turnover		 0.29 0.31 0.35 0.18 0.68 0.55 0.88 0.69 0.85 0.86
Increase / (Decrease) in Invested Capital		 229 370 220 -1,362 207 151 1,647 -448 444 -727
Enterprise Value (EV)		 1,777 1,969 2,051 311 -549 -689 391 1,047 1,852 2,617
Market Capitalization		 1,414 1,229 1,573 908 991 909 1,317 957 1,944 2,653
Book Value per Share		 $13.08 $13.29 $15.42 $12.79 $15.01 $16.37 $14.23 $11.56 $13.81 $10.73
Tangible Book Value per Share		 $13.08 $13.29 $15.42 $12.79 $15.01 $16.37 $13.16 $10.55 $12.90 $9.86
Total Capital		 2,093 2,463 2,683 1,321 1,528 1,680 3,327 2,879 3,323 2,596
Total Debt		 697 1,013 914 116 114 114 823 796 792 657
Total Long-Term Debt		 0.00 0.00 0.00 2.30 0.00 114 817 778 786 639
Net Debt		 346 704 364 -597 -1,540 -1,600 -1,125 -118 -309 -238
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 24 0.00 0.00 92 0.00 0.00 0.00 90 0.00 0.00
Net Nonoperating Obligations (NNO)		 697 1,013 914 116 114 114 823 796 792 657
Total Depreciation and Amortization (D&A)		 0.32 5.12 0.47 4.13 -1.40 -3.80 15 -9.10 -56 -49
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.84) $0.26 $2.71 ($3.27) $2.18 $1.54 $0.00 ($2.51) $1.93 $1.06
Adjusted Weighted Average Basic Shares Outstanding		 104.00M 104.06M 102.26M 97.05M 91.84M 92.51M 0.00 160.23M 163.34M 166.54M
Adjusted Diluted Earnings per Share		 ($0.84) $0.26 $2.64 ($3.27) $2.16 $1.53 $0.00 ($2.51) $1.85 $1.04
Adjusted Weighted Average Diluted Shares Outstanding		 104.00M 105.56M 105.23M 97.05M 92.65M 92.96M 0.00 160.23M 169.61M 169.47M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $2.18 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 106.13M 106.49M 103.28M 93.64M 94.21M 191.17M 0.00 162.38M 169.80M 162.23M
Normalized Net Operating Profit after Tax (NOPAT)		 -63 29 282 -225 495 321 303 27 554 651
Normalized NOPAT Margin		 -10.94% 4.12% 31.11% -62.57% 51.01% 36.62% 13.83% 1.29% 21.00% 25.60%
Pre Tax Income Margin		 -15.63% 4.92% 32.43% -89.38% 20.74% 17.33% 2.06% -19.82% 12.08% 9.16%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 35.71 -39.07 24.55 18.52 1.33 -10.95 4.97 3.35
NOPAT to Interest Expense		 0.00 0.00 34.26 -27.35 24.46 17.54 1.64 -7.67 5.67 2.91
EBIT Less CapEx to Interest Expense		 0.00 0.00 35.71 -39.07 24.55 18.52 1.33 -10.95 4.97 3.35
NOPAT Less CapEx to Interest Expense		 0.00 0.00 34.26 -27.35 24.46 17.54 1.64 -7.67 5.67 2.91
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% -30.85% 0.00% 0.00% 21.86% -4.15% 4.40% 7.91%
Augmented Payout Ratio		 0.00% 25.59% 14.50% -74.54% 0.00% 0.00% 21.86% -5.44% 4.40% 155.98%

Quarterly Metrics And Ratios for SiriusPoint

This table displays calculated financial ratios and metrics derived from SiriusPoint's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -13.44% 44.65% 79.06% 31.05% 7.02% 0.86% 0.53% 6.21% -20.33% -0.12% 6.39%
EBITDA Growth		 -97.07% 65.79% 174.04% 178.95% 160.26% 83.46% -38.22% 79.07% -101.48% -144.19% -23.61%
EBIT Growth		 -53.48% 74.92% 178.90% 192.72% 185.33% 95.08% -35.53% 66.02% -85.97% -563.16% -28.69%
NOPAT Growth		 -53.48% 72.32% 197.04% 205.52% 198.32% 95.54% -30.66% 85.46% -86.36% -563.16% -35.35%
Net Income Growth		 -97.47% 83.19% 164.84% 210.34% 168.16% 533.48% -30.66% 85.46% -86.36% -117.05% -35.35%
EPS Growth		 -79.41% 85.59% 154.41% 181.58% 152.46% 400.00% -33.78% 83.87% -90.63% -110.42% 0.00%
Operating Cash Flow Growth		 1,309.15% 292.00% 94,100.00% 148.56% -19.24% 344.58% -40.76% -231.04% -64.05% -49.53% -251.19%
Free Cash Flow Firm Growth		 126.39% 123.83% -18.19% -93.45% -122.17% -206.61% -256.40% -787.04% -162.68% 261.15% 429.13%
Invested Capital Growth		 -16.86% -13.46% -0.65% 1.05% 6.21% 15.44% 11.07% 10.47% 10.17% -21.88% -21.87%
Revenue Q/Q Growth		 22.97% -5.96% 10.57% 2.48% 0.43% -11.36% 10.20% 8.27% -24.67% 11.13% 17.37%
EBITDA Q/Q Growth		 -23.50% 48.46% 380.77% -55.82% -5.74% -114.14% 1,148.84% 28.05% -100.78% -2,233.33% 428.10%
EBIT Q/Q Growth		 -10.62% 58.36% 524.35% -52.56% 1.80% -102.40% 5,657.89% 22.16% -91.40% -213.51% 697.62%
NOPAT Q/Q Growth		 -10.62% 54.05% 563.78% -55.24% 3.07% -102.08% 7,310.53% 19.71% -92.42% -201.38% 802.95%
Net Income Q/Q Growth		 -66.84% 75.43% 701.30% -55.24% 3.07% 56.27% -3.81% 19.71% -92.42% -295.40% 464.71%
EPS Q/Q Growth		 -60.53% 73.77% 562.50% -58.11% 3.23% 50.00% 2.08% 16.33% -94.74% -266.67% 1,080.00%
Operating Cash Flow Q/Q Growth		 343.68% -76.01% 96.25% 19.00% 44.16% 32.05% -73.85% -363.26% 139.55% 85.37% -182.54%
Free Cash Flow Firm Q/Q Growth		 13.45% -19.76% -62.04% -81.03% -483.72% -285.91% 44.32% 16.68% -46.71% 336.74% 13.73%
Invested Capital Q/Q Growth		 -5.01% -0.35% 7.96% -1.12% -0.15% 8.31% 3.87% -1.66% -0.42% -23.20% 3.89%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 -15.77% -8.64% 21.95% 9.46% 8.88% -1.42% 13.49% 15.95% -0.17% -3.46% 9.69%
EBIT Margin		 -14.49% -6.42% 24.62% 11.40% 11.55% -0.31% 15.79% 17.82% 2.04% -2.08% 10.58%
Profit (Net Income) Margin		 -14.63% -3.82% 20.79% 9.08% 9.32% 16.43% 14.34% 15.86% 1.60% -2.80% 8.72%
Tax Burden Percent		 100.97% 53.99% 84.43% 79.67% 80.66% -5,247.37% 90.81% 88.99% 78.38% 134.92% 82.34%
Interest Burden Percent		 100.00% 110.36% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 15.57% 20.33% 19.34% 0.00% 9.19% 11.01% 21.62% 0.00% 17.66%
Return on Invested Capital (ROIC)		 -6.21% -3.41% 16.18% 7.69% 8.24% -0.19% 11.55% 13.16% 1.26% -1.25% 7.33%
ROIC Less NNEP Spread (ROIC-NNEP)		 -9.73% -2.57% 16.18% 7.69% 8.24% 12.53% 11.55% 13.16% 1.26% -2.38% 7.33%
Return on Net Nonoperating Assets (RNNOA)		 -3.36% -0.91% 6.07% 2.78% 3.02% 4.32% 4.01% 3.95% 0.38% -0.77% 2.37%
Return on Equity (ROE)		 -9.56% -4.31% 22.25% 10.46% 11.26% 4.13% 15.56% 17.12% 1.64% -2.02% 9.70%
Cash Return on Invested Capital (CROIC)		 6.67% 4.90% -0.59% 1.69% 2.07% -2.60% -0.70% 1.63% 0.22% 31.41% 30.04%
Operating Return on Assets (OROA)		 -2.60% -1.26% 5.26% 2.51% 2.58% -0.07% 3.35% 3.77% 0.41% -0.42% 2.15%
Return on Assets (ROA)		 -2.62% -0.75% 4.44% 2.00% 2.08% 3.63% 3.04% 3.35% 0.32% -0.56% 1.77%
Return on Common Equity (ROCE)		 -8.74% -3.93% 20.23% 9.50% 10.17% 3.75% 14.19% 15.69% 1.50% -1.83% 8.83%
Return on Equity Simple (ROE_SIMPLE)		 -23.98% 0.00% -1.54% 3.71% 10.71% 0.00% 12.35% 13.84% 11.84% 0.00% 8.32%
Net Operating Profit after Tax (NOPAT)		 -65 -30 138 62 64 -1.33 96 115 8.70 -8.82 62
NOPAT Margin		 -10.14% -4.96% 20.79% 9.08% 9.32% -0.22% 14.34% 15.86% 1.60% -1.46% 8.72%
Net Nonoperating Expense Percent (NNEP)		 3.52% -0.84% 0.00% 0.00% 0.00% -12.72% 0.00% 0.00% 0.00% 1.13% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 114.49% 106.42% 75.38% 88.60% 88.45% 100.31% 84.21% 82.18% 97.96% 102.08% 89.42%
Earnings before Interest and Taxes (EBIT)		 -93 -39 164 78 79 -1.90 106 129 11 -13 75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -101 -52 146 65 61 -8.60 90 116 -0.90 -21 69
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.43 0.51 0.65 0.72 0.82 0.84 0.90 0.83 0.98 1.53 1.54
Price to Tangible Book Value (P/TBV)		 0.47 0.56 0.70 0.78 0.88 0.90 0.96 0.88 1.04 1.66 1.66
Price to Revenue (P/Rev)		 0.41 0.45 0.54 0.57 0.64 0.74 0.82 0.77 0.96 1.04 1.08
Price to Earnings (P/E)		 0.00 0.00 0.00 18.67 7.13 5.48 6.88 5.66 7.79 13.27 16.83
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 5.36% 14.03% 18.25% 14.54% 17.68% 12.84% 7.53% 5.94%
Enterprise Value to Invested Capital (EV/IC)		 0.35 0.36 0.46 0.56 0.61 0.56 0.61 0.66 0.75 1.01 1.02
Enterprise Value to Revenue (EV/Rev)		 0.52 0.49 0.58 0.66 0.71 0.70 0.80 0.84 0.99 1.03 1.06
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 29.83 8.57 7.05 10.25 8.71 12.85 14.24 16.93
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 15.59 6.67 5.81 8.14 7.20 10.34 11.23 13.57
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 20.55 7.80 5.09 6.60 6.00 7.90 12.93 16.33
Enterprise Value to Operating Cash Flow (EV/OCF)		 4.61 3.57 3.66 3.78 4.52 3.19 3.91 7.91 13.97 35.03 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 4.79 6.89 0.00 33.17 30.47 0.00 0.00 42.70 360.10 2.82 2.98
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.38 0.38 0.38 0.36 0.35 0.31 0.32 0.25 0.25 0.34 0.33
Long-Term Debt to Equity		 0.36 0.37 0.35 0.34 0.34 0.31 0.29 0.24 0.24 0.33 0.33
Financial Leverage		 0.35 0.35 0.37 0.36 0.37 0.34 0.35 0.30 0.30 0.32 0.32
Leverage Ratio		 4.59 4.72 5.01 5.22 5.41 5.18 5.12 5.10 5.09 5.68 5.47
Compound Leverage Factor		 4.59 5.21 5.01 5.22 5.41 5.18 5.12 5.10 5.09 5.68 5.47
Debt to Total Capital		 27.55% 27.65% 27.66% 26.20% 26.16% 23.85% 24.08% 20.29% 20.22% 25.31% 24.85%
Short-Term Debt to Total Capital		 1.17% 0.63% 2.59% 1.27% 1.27% 0.19% 1.76% 1.18% 0.68% 0.69% 0.24%
Long-Term Debt to Total Capital		 26.38% 27.03% 25.07% 24.93% 24.89% 23.66% 22.33% 19.11% 19.54% 24.62% 24.60%
Preferred Equity to Total Capital		 6.92% 6.95% 6.44% 6.51% 6.52% 6.02% 5.79% 5.89% 5.92% 7.70% 7.42%
Noncontrolling Interests to Total Capital		 0.29% 0.27% 0.37% 0.42% 0.50% 0.50% 0.52% 0.04% 0.05% 0.05% 0.06%
Common Equity to Total Capital		 65.24% 65.13% 65.54% 66.87% 66.82% 69.63% 69.61% 73.77% 73.81% 66.93% 67.68%
Debt to EBITDA		 -1.50 -1.84 -9.70 13.98 3.66 3.02 4.02 2.67 3.48 3.58 4.12
Net Debt to EBITDA		 -0.01 0.27 1.30 0.58 -0.04 -1.18 -1.23 -0.14 -0.67 -1.29 -1.57
Long-Term Debt to EBITDA		 -1.43 -1.80 -8.79 13.30 3.48 2.99 3.72 2.51 3.37 3.48 4.08
Debt to NOPAT		 -2.13 -2.69 -22.21 9.63 3.33 2.18 2.59 1.84 2.14 3.25 3.98
Net Debt to NOPAT		 -0.01 0.40 2.97 0.40 -0.04 -0.85 -0.79 -0.09 -0.41 -1.17 -1.51
Long-Term Debt to NOPAT		 -2.04 -2.63 -20.13 9.16 3.17 2.16 2.40 1.73 2.07 3.16 3.94
Noncontrolling Interest Sharing Ratio		 8.63% 8.89% 9.06% 9.21% 9.72% 9.20% 8.82% 8.33% 8.40% 9.35% 9.02%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 521 418 159 30 -116 -446 -248 -207 -303 718 817
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 55.43 39.82 12.40 2.57 -5.83 -22.51 -12.11 -13.17 -21.99 36.65 45.13
Operating Cash Flow to Interest Expense		 21.29 4.57 7.36 9.58 8.16 10.78 2.72 -9.36 4.21 5.49 -4.91
Operating Cash Flow Less CapEx to Interest Expense		 21.29 4.57 7.36 9.58 8.16 10.78 2.72 -9.36 4.21 5.49 -4.91
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.18 0.20 0.21 0.22 0.22 0.22 0.21 0.21 0.20 0.20 0.20
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,889 2,879 3,108 3,073 3,068 3,323 3,452 3,394 3,380 2,596 2,697
Invested Capital Turnover		 0.61 0.69 0.78 0.85 0.88 0.85 0.81 0.83 0.79 0.86 0.84
Increase / (Decrease) in Invested Capital		 -586 -448 -20 32 179 444 344 322 312 -727 -755
Enterprise Value (EV)		 1,016 1,047 1,417 1,718 1,880 1,852 2,121 2,246 2,521 2,617 2,751
Market Capitalization		 804 957 1,320 1,471 1,673 1,944 2,158 2,080 2,451 2,653 2,805
Book Value per Share		 $11.61 $11.56 $12.54 $12.61 $12.46 $13.81 $14.15 $14.69 $14.60 $10.73 $11.25
Tangible Book Value per Share		 $10.59 $10.55 $11.55 $11.64 $11.52 $12.90 $13.27 $13.83 $13.76 $9.86 $10.40
Total Capital		 2,889 2,879 3,108 3,073 3,068 3,323 3,452 3,394 3,380 2,596 2,697
Total Debt		 796 796 860 805 803 792 831 689 684 657 670
Total Long-Term Debt		 762 778 779 766 764 786 771 649 661 639 664
Net Debt		 4.40 -118 -115 34 -8.60 -309 -255 -35 -132 -238 -255
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 29 -6.82 0.00 0.00 0.00 -101 0.00 0.00 0.00 8.18 0.00
Net Nonoperating Obligations (NNO)		 796 796 860 805 803 792 831 689 684 657 670
Total Depreciation and Amortization (D&A)		 -8.20 -13 -18 -13 -18 -6.70 -15 -14 -12 -8.40 -6.40
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.61) ($0.16) $0.00 $0.38 $0.00 $0.52 $0.50 $0.60 $0.03 ($0.07) $0.50
Adjusted Weighted Average Basic Shares Outstanding		 160.32M 160.23M 0.00 162.03M 0.00 163.34M 168.93M 170.17M 165.66M 166.54M 115.98M
Adjusted Diluted Earnings per Share		 ($0.61) ($0.16) $0.00 $0.37 $0.00 $0.48 $0.49 $0.57 $0.03 ($0.05) $0.49
Adjusted Weighted Average Diluted Shares Outstanding		 160.32M 160.23M 0.00 166.71M 0.00 169.61M 174.38M 178.71M 172.80M 169.47M 118.56M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 162.17M 162.38M 0.00 164.50M 0.00 169.80M 170.48M 170.90M 161.87M 162.23M 116.59M
Normalized Net Operating Profit after Tax (NOPAT)		 17 -30 239 151 168 77 227 222 101 85 169
Normalized NOPAT Margin		 2.64% -4.96% 35.98% 22.15% 24.58% 12.67% 34.02% 30.59% 18.48% 14.09% 23.73%
Pre Tax Income Margin		 -14.49% -7.08% 24.62% 11.40% 11.55% -0.31% 15.79% 17.82% 2.04% -2.08% 10.58%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -9.86 -3.68 12.80 6.64 3.99 -0.10 5.15 8.22 0.80 -0.64 4.16
NOPAT to Interest Expense		 -6.90 -2.84 10.80 5.29 3.22 -0.07 4.68 7.31 0.63 -0.45 3.43
EBIT Less CapEx to Interest Expense		 -9.86 -3.68 12.80 6.64 3.99 -0.10 5.15 8.22 0.80 -0.64 4.16
NOPAT Less CapEx to Interest Expense		 -6.90 -2.84 10.80 5.29 3.22 -0.07 4.68 7.31 0.63 -0.45 3.43
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -3.20% -4.15% -46.51% 19.14% 6.64% 4.40% 4.98% 4.28% 5.01% 7.91% 9.50%
Augmented Payout Ratio		 -4.20% -5.44% -46.51% 19.14% 6.64% 4.40% 4.98% 4.28% 45.66% 155.98% 478.64%

Key Financial Trends

The latest financial data for SiriusPoint (NYSE: SPNT) through Q1 2025 shows a mix of positive developments and some ongoing challenges. Below is an analysis of key points from the last four years of quarterly data focusing on trends in income, cash flow, and balance sheet positions.

  • SiriusPoint reported a net income of $62.0 million in Q1 2025, a significant improvement from losses in recent quarters such as Q4 2024, which had a net loss of $17.0 million.
  • Total revenue grew to $711.4 million in Q1 2025, up from $606.1 million in Q4 2024, driven by higher premiums earned ($626.7 million) and strong non-interest income ($729.5 million).
  • Premiums earned have generally increased over the last year, from around $590 million in mid-2024 to over $626 million in Q1 2025, indicating growth in core insurance operations.
  • Net realized and unrealized capital gains on investments were $73.1 million in Q1 2025, improving from lower gains and some losses in prior quarters, supporting profitability.
  • Operating cash flow turned positive recently in some quarters (e.g., Q4 2023 and Q3 2023) with over $200 million net cash from operating activities, reflecting improved earnings quality and working capital management.
  • The company continues to carry a long-term debt balance around $660 million to $770 million, with associated interest expenses fluctuating but remaining a meaningful cost (e.g., $18.1 million in Q1 2025).
  • Restructuring charges are consistently high, recently $129.7 million in Q1 2025, which continues to weigh on earnings though reflects ongoing organizational changes.
  • Share count has decreased from roughly 170 million shares in early 2024 to about 116 million in Q1 2025, partly due to repurchases; this dilution reduction boosts per-share metrics.
  • There is continued volatility in non-interest income components related to investments, with swings in capital gains impacting quarters positively or negatively.
  • Net cash from operating activities was negative $88.9 million in Q1 2025, contrasting with positive cash flows in some previous quarters, signaling potential operational or working capital challenges.

Summary: SiriusPoint has demonstrated improving earnings in recent quarters, highlighted by a return to profitability in Q1 2025 and growth in insurance premiums and investment income. However, restructuring costs remain elevated, and operating cash flow volatility suggests careful monitoring is needed. The company’s leverage and interest expenses are stable but significant. Ongoing share repurchases are beneficial for shareholders in enhancing per-share earnings. Overall, the trend shows operational recovery and growth with cautious attention needed on cash flows and restructuring impact.

08/29/25 04:02 AM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About SiriusPoint's Financials

When does SiriusPoint's financial year end?

According to the most recent income statement we have on file, SiriusPoint's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has SiriusPoint's net income changed over the last 9 years?

SiriusPoint's net income appears to be on an upward trend, with a most recent value of $202.40 million in 2024, falling from -$87.44 million in 2015. The previous period was $363.70 million in 2023. See where experts think SiriusPoint is headed by visiting SiriusPoint's forecast page.

How has SiriusPoint's revenue changed over the last 9 years?

Over the last 9 years, SiriusPoint's total revenue changed from $577.95 million in 2015 to $2.54 billion in 2024, a change of 340.2%.

How much debt does SiriusPoint have?

SiriusPoint's total liabilities were at $10.59 billion at the end of 2024, a 2.4% increase from 2023, and a 392.6% increase since 2015.

How much cash does SiriusPoint have?

In the past 9 years, SiriusPoint's cash and equivalents has ranged from $8.20 million in 2017 to $999.80 million in 2021, and is currently $682 million as of their latest financial filing in 2024.

How has SiriusPoint's book value per share changed over the last 9 years?

Over the last 9 years, SiriusPoint's book value per share changed from 13.08 in 2015 to 10.73 in 2024, a change of -17.9%.


Related Companies

This page (NYSE:SPNT) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel